Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Second-Line Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer
NCT00720512Phase 3Terminated
- Sponsor
- Gruppo Oncologico Nord Ovest
- Start
- Jun 2008
- Primary completion
- Feb 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in colorectal cancer (CRC), sponsored by Gruppo Oncologico Nord Ovest. Started Jun 2008; status: terminated.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00720512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00720512.